Cas No.: | 1401066-79-2 |
Chemical Name: | (2R,3S)-N1-[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)-butanediamide |
Synonyms: | BMS 906024;BMS906024 |
SMILES: | C(N[C@@H]1N=C(C2=CC=CC=C2)C2=CC=CC=C2N(C)C1=O)(=O)[C@@H](CCC(F)(F)F)[C@@H](CCC(F)(F)F)C(N)=O |
Formula: | C26H26F6N4O3 |
M.Wt: | 556.50 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | BMS-906024 is a highly potent, selective inhibitor of γ-secretase mediated signaling of Notch1/2/3/4 receptors with IC50 of 1.6/0.7/3.4/2.9 nM, respectively; exhibits >200-fold selectivity against a panel of diverse protein targets; inhibits both leukemia (TALL-1) and triple-negative breast cancer (MDA-MB-468) cells with IC50 of 0.4 nM, demonstrates broad-spectrum antineoplastic activity against a wide array of human cancer xenografts |